Stocks · News reference
8-K filing — MIRA PHARMACEUTICALS, INC. (MIRA)
Filed: 2026-07-31 AccNo: 0001493152-26-035665 Size: 207 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 31, 2026, 9:00 PM
- Checked
- Jul 31, 2026, 9:00 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — MIRA PHARMACEUTICALS, INC. (MIRA)
Filed: 2026-08-06 AccNo: 0001493152-26-036262 Size: 234 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarMIRA Pharmaceuticals Says It Completed Dosing In Exploratory Non-GLP 7-Day Toxicology Studies Of MIRA-55 And SKNY-1, Advancing Both Toward IND-Enabling Development
Read original at benzingaMIRA Pharma Announces Results Preclinical Studies Evaluating Optimized Oral Formulations Of MIRA-55, Oral Drug Candidate Being Developed As Non-Opioid Therapy For Chronic Inflammatory Pain
Read original at benzinga